additional_assessments
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
additional_assessments [2023/09/08 09:03] trynke [Table] |
additional_assessments [2024/10/15 10:45] (current) trynke |
||
|---|---|---|---|
| Line 3: | Line 3: | ||
| On top of the [[general assessments]], additional assessments may be performed in selected groups of Lifelines [[cohort|participants]] (e.g. "subcohorts") in order to collect additional questionnaire data, measurements and/or biomaterials. \\ | On top of the [[general assessments]], additional assessments may be performed in selected groups of Lifelines [[cohort|participants]] (e.g. "subcohorts") in order to collect additional questionnaire data, measurements and/or biomaterials. \\ | ||
| Additional assessments are performed at the initiative of (and in collaboration with) external research groups, and an embargo period for use of additional data by third parties may apply.\\ | Additional assessments are performed at the initiative of (and in collaboration with) external research groups, and an embargo period for use of additional data by third parties may apply.\\ | ||
| - | The following additional assessments have been performed: | + | |
| + | The following additional measurements/sample collections have been performed: | ||
| + | * [[DEEP|DAG1]], a.k.a. **DEEP**, analysis of **microbiome** and methylome in samples of ca. ~1.500 participants | ||
| + | * [[DAG2]], the assessment of **whole genome** + fecal **microbiome** in samples of ca. 165 participants | ||
| + | * [[DAG3]], the assessment of the **microbiome** in samples of ca. ~9.000 participants | ||
| + | * [[DAG4]], the follow-up to [[DAG3]] | ||
| + | * [[DAG5]], the follow-up to [[DAG4]] | ||
| + | * [[EYEL]], the assessment of glaucoma in elderly participants (**EyeLife**) | ||
| + | * [[GWAS]], the **genotyping** of ~15.000 participants | ||
| + | * [[UGLI]], the **genotyping** of ~38.500 (UGLI-1) plus ~28,000 (UGLI-2) participants | ||
| + | * [[HAIR]], the collection & analysis of scalp **hair** samples | ||
| + | * [[IMAL]], the assessment of CT scans of the lungs & hearts of ~12.000 participants (**ImaLife**) | ||
| + | * [[MYST]], the use of **quantified-self** devices in ~100 participants | ||
| + | * [[PGXP]], the use of a **pharmacogenetic passport** in an app by ~1000 participants | ||
| + | * [[NEXT]], the assessment of ~1500 **pregnant** Lifelines participants (currently an independent project) | ||
| + | * [[SALT]], additional urine analyses and questionnaire on salt usage | ||
| + | * [[VESP]], the assessment of fertility, sperm quality and plasma hormones in ~200 participants (**Vesper**) | ||
| + | |||
| + | The following additional questionnaires have been performed: | ||
| * [[ACNQ]], a questionnaire on **acne** | * [[ACNQ]], a questionnaire on **acne** | ||
| * [[ACTQ]], a questionnaire on daily activities and leisure activities (**DALAS**) | * [[ACTQ]], a questionnaire on daily activities and leisure activities (**DALAS**) | ||
| Line 10: | Line 28: | ||
| * [[BIGQ]], a questionnaire on values and beliefs around **big data** use | * [[BIGQ]], a questionnaire on values and beliefs around **big data** use | ||
| * [[BLUQ]], a questionnaire on children's exposure to **blue light** | * [[BLUQ]], a questionnaire on children's exposure to **blue light** | ||
| - | * [[COVQ]], a series of questionnaires on **covid-19**, ongoing | + | * [[COVQ]], a series of questionnaires during the **covid-19** pandemic |
| - | * [[DEEP|DAG1]], a.k.a. **DEEP**, the assessment of the **microbiome** and methylome of ca. ~1.500 participants | + | |
| - | * [[DAG2]], the assessment of **whole genome** + **microbiome** in ca. 165 participants | + | |
| - | * [[DAG3]], the assessment of the **microbiome** of ca. ~9.000 participants | + | |
| * [[DCDQ]], a questionnaire on **motoric** development | * [[DCDQ]], a questionnaire on **motoric** development | ||
| - | * [[BIONIC|DEAQ]], a questionnaire on lifetime **depression** and **anxiety** ([[BIONIC]]-II) | ||
| * [[BIONIC|DEPQ]], a questionnaire on lifetime **depression** ([[BIONIC]]-I) | * [[BIONIC|DEPQ]], a questionnaire on lifetime **depression** ([[BIONIC]]-I) | ||
| + | * [[BIONIC|DEAQ]], a questionnaire on lifetime **depression** and **anxiety** ([[BIONIC]]-II) | ||
| * [[DIVQ]], a questionnaire on well-being and the kinship network after parental divorce | * [[DIVQ]], a questionnaire on well-being and the kinship network after parental divorce | ||
| * [[EARQ]], a questionnaire on experiences with **earthquakes** | * [[EARQ]], a questionnaire on experiences with **earthquakes** | ||
| - | * [[EYEL]], the assessment of glaucoma in elderly participants (**EyeLife**, ongoing) | ||
| - | * [[GWAS]], the **genotyping** of ~15.000 participants (freely available) | ||
| - | * [[HAIR]], the collection & analysis of scalp **hair** samples | ||
| * [[INFQ]], a questionnaire on informal care (**ICAS**) | * [[INFQ]], a questionnaire on informal care (**ICAS**) | ||
| - | * [[IMAL]], the assessment of CT scans of the lungs & hearts of ~12.000 participants (**ImaLife**, ongoing) | ||
| * [[MAWQ]], a questionnaire on **menopause** and **work** | * [[MAWQ]], a questionnaire on **menopause** and **work** | ||
| + | * [[MCFQ]], a questionnaire on myalgic encephalomyelitis/chronic fatigue syndrome | ||
| * [[MHDQ]], a questionnaire on the links between (familial) **mental health** and **diabetes** | * [[MHDQ]], a questionnaire on the links between (familial) **mental health** and **diabetes** | ||
| * [[MUSQ]], a questionnaire on **language** use and **musical** training | * [[MUSQ]], a questionnaire on **language** use and **musical** training | ||
| - | * [[MYST]], the use of **quantified-self** devices in ~100 participants | + | * [[OPBQ]], a questionnaire on **optimism**, parental bonding and emotion regulation |
| - | * [[NEXT]], the assessment of ~1500 **pregnant** Lifelines participants, their partners, and their babies (ongoing) | + | * [[RELQ]], a questionnaire on the cognitive benefits of **regional language** use |
| - | * [[OPTQ]], a questionnaire on **optimism** and emotion regulation | + | |
| * [[ROAQ]], a questionnaire on female reproductive health (**ROAHD**) | * [[ROAQ]], a questionnaire on female reproductive health (**ROAHD**) | ||
| - | * [[SALT]], additional urine analyses and questionnaire on salt usage | ||
| * [[SHIQ]], a questionnaire on **shiftwork** and irregular working hours | * [[SHIQ]], a questionnaire on **shiftwork** and irregular working hours | ||
| * [[SKIQ]], a questionnaire on the **skin conditions** hidradentitis supperative and eczema | * [[SKIQ]], a questionnaire on the **skin conditions** hidradentitis supperative and eczema | ||
| * [[SPEQ]], a questionnaire on **speech, language, and music** | * [[SPEQ]], a questionnaire on **speech, language, and music** | ||
| - | * [[UGLI]], the **genotyping** of ~38.500 participants (freely available) | ||
| - | * [[VESP]], the assessment of fertility, sperm quality and plasma hormones in ~200 participants (**Vesper**) | ||
| - | \\ | ||
| \\ | \\ | ||
| ===== Timeline Additional Assesments ===== | ===== Timeline Additional Assesments ===== | ||
| - | | **<2012** | | [[1A]] | [[1B]] | | | | | | | | | | + | | **<2012** | | [[1A]] | [[1B]] | | | | | | | | |
| - | | **2012** | q1 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | | | | + | | **2012** | q1 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | | |
| - | | ::: | q2 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | [[DEEP]] | | | | | + | | ::: | q2 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | [[DEEP]] | |
| - | | ::: | q3 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | [[DEEP]] | | | | | + | | ::: | q3 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | [[DEEP]] | |
| - | | ::: | q4 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | [[DEEP]] | | | | | + | | ::: | q4 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | [[DEEP]] | |
| - | | **2013** | q1 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | | | | + | | **2013** | q1 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | | |
| - | | ::: | q2 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | | | | + | | ::: | q2 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | | |
| - | | ::: | q3 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | [[INFQ]] | | | | | + | | ::: | q3 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | [[INFQ]] | |
| - | | ::: | q4 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | [[INFQ]] | [[HAIR]] | | | | + | | ::: | q4 | [[1A]] | [[1B]] | [[1C]] | [[2A]] | | | | | [[INFQ]] + [[HAIR]] | |
| - | | **2014** | q1 | | [[1B]] | [[1C]] | [[2A]] | | | [[INFQ]] | | | | | + | | **2014** | q1 | | [[1B]] | [[1C]] | [[2A]] | | | | | [[INFQ]] | |
| - | | ::: | q2 | | [[1B]] | [[1C]] | [[2A]] | | | [[INFQ]] | | | | | + | | ::: | q2 | | [[1B]] | [[1C]] | [[2A]] | | | | | [[INFQ]] | |
| - | | ::: | q3 | | [[1B]] | [[1C]] | [[2A]] | | | | | | | | + | | ::: | q3 | | [[1B]] | [[1C]] | [[2A]] | | | | | | |
| - | | ::: | q4 | | [[1B]] | [[1C]] | [[2A]] | | | | | | | | + | | ::: | q4 | | [[1B]] | [[1C]] | [[2A]] | | | | | | |
| - | | **2015** | q1 | | | [[1C]] | [[2A]] | | | | | | | | + | | **2015** | q1 | | | [[1C]] | [[2A]] | | | | | | |
| - | | ::: | q2 | | | [[1C]] | [[2A]] | | | [[ACNQ]] | | | | | + | | ::: | q2 | | | [[1C]] | [[2A]] | | | | | [[ACNQ]] | |
| - | | ::: | q3 | | | [[1C]] | [[2A]] | | | [[DAG3]] | | | | | + | | ::: | q3 | | | [[1C]] | [[2A]] | | | | | [[DAG3]] | |
| - | | ::: | q4 | | | [[1C]] | [[2A]] | | | [[DAG3]] | | | | | + | | ::: | q4 | | | [[1C]] | [[2A]] | | | | | [[DAG3]] | |
| - | | **2016** | q1 | | | | [[2A]] | [[2B]] | | [[DAG3]] | [[BIONIC|DEPQ]] | | | | + | | **2016** | q1 | | | | [[2A]] | [[2B]] | | | | [[DAG3]] + [[BIONIC|DEPQ]] | |
| - | | ::: | q2 | | | | [[2A]] | [[2B]] | | [[DAG3]] | [[MYST]] | | | | + | | ::: | q2 | | | | [[2A]] | [[2B]] | | | | [[DAG3]] + [[MYST]] | |
| - | | ::: | q3 | | | | [[2A]] | [[2B]] | | [[DAG3]] | [[MYST]] | | | | + | | ::: | q3 | | | | [[2A]] | [[2B]] | | | | [[DAG3]] + [[MYST]] | |
| - | | ::: | q4 | | | | [[2A]] | [[2B]] | | [[EARQ]] | [[NEXT]] | | | | + | | ::: | q4 | | | | [[2A]] | [[2B]] | | | | [[EARQ]] | |
| - | | **2017** | q1 | | | | [[2A]] | [[2B]] | | | [[NEXT]] | | | | + | | **2017** | q1 | | | | [[2A]] | [[2B]] | | | | | |
| - | | ::: | q2 | | | | [[2A]] | [[2B]] | | | [[NEXT]] | [[DCDQ]] | [[ADHQ]] | | + | | ::: | q2 | | | | [[2A]] | [[2B]] | | | | [[ADHQ]] + [[DCDQ]] + [[ACTQ]] | |
| - | | ::: | q3 | | | | [[2A]] | [[2B]] | | | [[NEXT]] | | | | + | | ::: | q3 | | | | [[2A]] | [[2B]] | | | | [[ACTQ]] + [[ROAQ]] | |
| - | | ::: | q4 | | | | [[2A]] | [[2B]] | | [[IMAL]] | [[NEXT]] | [[ROAQ]] | [[SHIQ]] | | + | | ::: | q4 | | | | [[2A]] | [[2B]] | | | | [[IMAL]] + [[ACTQ]] + [[ROAQ]] + [[SHIQ]] + [[DIVQ]] | |
| - | | **2018** | q1 | | | | | [[2B]] | | [[IMAL]] | [[NEXT]] | [[BLUQ]] | [[ADHQ]] | | + | | **2018** | q1 | | | | | [[2B]] | | | | [[IMAL]] + [[ACTQ]] + [[ROAQ]] + [[ADHQ]] + [[BLUQ]]+ [[DIVQ]] | |
| - | | ::: | q2 | | | | | [[2B]] | | [[IMAL]] | [[NEXT]] | [[BLUQ]] | [[BIONIC|DEAQ]] | | + | | ::: | q2 | | | | | [[2B]] | | | | [[IMAL]] + [[BLUQ]] + [[BIONIC|DEAQ]] + [[DIVQ]] | |
| - | | ::: | q3 | | | | | [[2B]] | | [[IMAL]] | [[NEXT]] | [[BIGQ]] | [[BIONIC|DEAQ]] | | + | | ::: | q3 | | | | | [[2B]] | | | | [[IMAL]] + [[BIGQ]] + [[BIONIC|DEAQ]] + [[DIVQ]] | |
| - | | ::: | q4 | | | | | [[2B]] | | [[IMAL]] | [[NEXT]] | [[BIGQ]] | | | + | | ::: | q4 | | | | | [[2B]] | | | | [[IMAL]] + [[BIGQ]] + [[DIVQ]] | |
| - | | **2019** | q1 | | | | | [[2B]] | | [[IMAL]] | [[NEXT]] | | [[ADHQ]] | | + | | **2019** | q1 | | | | | [[2B]] | | | | [[IMAL]] + [[ADHQ]]+ [[DIVQ]] | |
| - | | ::: | q2 | | | | | [[2B]] | | [[IMAL]] | [[NEXT]] | | | | + | | ::: | q2 | | | | | [[2B]] | | | | [[IMAL]]+ [[DIVQ]] | |
| - | | ::: | q3 | | | | | [[2B]] | [[3A]] | [[IMAL]] | [[VESP]] | [[EYEL]] | [[AUTQ]] | | + | | ::: | q3 | | | | | [[2B]] | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[AUTQ]] | |
| - | | ::: | q4 | | | | | [[2B]] | [[3A]] | [[IMAL]] | [[VESP]] | [[MUSQ]] | | | + | | ::: | q4 | | | | | [[2B]] | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[MUSQ]] | |
| - | | **2020** | q1 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | [[MUSQ]] | [[SKIQ]] | | + | | **2020** | q1 | | | | | | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[MUSQ]] + [[SKIQ]] | |
| - | | ::: | q2 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | [[COVQ]] | [[SKIQ]] | | + | | ::: | q2 | | | | | | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[COVQ]] + [[SKIQ]] | |
| - | | ::: | q3 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | [[COVQ]] | | | + | | ::: | q3 | | | | | | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[COVQ]] | |
| - | | ::: | q4 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | [[COVQ]] | | | + | | ::: | q4 | | | | | | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[COVQ]] + [[SALT]] | |
| - | | **2021** | q1 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | [[COVQ]] | | | + | | **2021** | q1 | | | | | | [[3A]] | | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[COVQ]] | |
| - | | | q2 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | [[COVQ]] | [[MAWQ]] | | + | | | q2 | | | | | | [[3A]] | [[3B]] | | [[IMAL]] + [[VESP]] + [[EYEL]] + [[COVQ]] + [[MAWQ]] | |
| - | | | q3 | | | | | | [[3A]] | [[IMAL]] | [[VESP]] | | | | + | | | q3 | | | | | | [[3A]] | [[3B]] | | [[IMAL]] + [[COVQ]] + [[RELQ]] | |
| - | | | q4 | | | | | | [[3A]] | [[IMAL]] | | | | | + | | | q4 | | | | | | [[3A]] | [[3B]] | | [[IMAL]] + [[COVQ]] | |
| - | | **2022** | q1 | | | | | | | | | | | | + | | **2022** | q1 | | | | | | [[3A]] | [[3B]] | | [[IMAL]] + [[COVQ]] | |
| - | | | q2 | | | | | | | | | | | | + | | | q2 | | | | | | [[3A]] | [[3B]] | | [[IMAL]] + [[COVQ]] | |
| - | | | q3 | | | | | | | | | | | | + | | | q3 | | | | | | [[3A]] | [[3B]] | | [[IMAL]] + [[COVQ]] + [[SPEQ]] | |
| - | | | q4 | | | | | | | | | | | | + | | | q4 | | | | | | [[3A]] | [[3B]] | | | |
| + | | **2023** | q1 | | | | | | [[3A]] | [[3B]] | | [[MHDQ]] | | ||
| + | | | q2 | | | | | | [[3A]] | [[3B]] | | [[MHDQ]] | | ||
| + | | | q3 | | | | | | [[3A]] | [[3B]] | | [[OPBQ]] | | ||
| + | | | q4 | | | | | | [[3A]] | [[3B]] | | [[OPBQ]] + [[MCFQ]] | | ||
| + | | **2024** | q1 | | | | | | | [[3B]] | [[4A]] | [[MCFQ]] | | ||
additional_assessments.1694156582.txt.gz · Last modified: 2023/09/08 09:03 by trynke
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
